CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PharmaTimes
Original article

Kither begins dosing in COPD trial of KIT2014

Trial StartKIT2014Neutral
AI Analysis

Summary

Kither has begun dosing patients in an early-stage trial of KIT2014 for COPD to assess safety and efficacy signals.

Clinical Trial Data

Phase

1

Importance:3/10
Sentiment:
0.20
COPDclinical trialearly-stagesafetyefficacy

Read the original article

Published by PharmaTimes on October 5, 2026 9:54 AM

Read Original